Shanghai Model Organisms Center, Inc. (SHA:688265)
26.83
+0.68 (2.60%)
May 16, 2025, 2:45 PM CST
SHA:688265 Revenue
Shanghai Model Organisms Center had revenue of 88.40M CNY in the quarter ending March 31, 2025, with 6.59% growth. This brings the company's revenue in the last twelve months to 387.40M, up 6.96% year-over-year. In the year 2024, Shanghai Model Organisms Center had annual revenue of 381.93M with 4.20% growth.
Revenue (ttm)
387.40M
Revenue Growth
+6.96%
P/S Ratio
5.24
Revenue / Employee
498.58K
Employees
777
Market Cap
2.03B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 381.93M | 15.39M | 4.20% |
Dec 31, 2023 | 366.55M | 63.58M | 20.99% |
Dec 31, 2022 | 302.97M | 27.70M | 10.06% |
Dec 31, 2021 | 275.27M | 79.08M | 40.31% |
Dec 31, 2020 | 196.19M | 41.39M | 26.74% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 39.59B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Sichuan Biokin Pharmaceutical | 5.82B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |